Feasibility and Efficacy of Neoadjuvant Cabozantinib Plus Nivolumab (CaboNivo) Followed by Definitive Resection for Patients With Locally Advanced Hepatocellular Carcinoma (HCC)
Clinical trial NCT03299946 · COMPLETED
Trial details
- NCT number
- NCT03299946
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-14
- Primary completion
- 2019-12-09
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.